Form 4: Exact Sciences Executive Brian Baranick Reports Stock Transactions
SEC Form 4
Brian Baranick, General Manager of Precision Oncology at Exact Sciences, reports the vesting of restricted stock units, subsequent sale of shares to cover taxes, and new grants of restricted stock units.
Summary
- On February 26, 2024, Brian Baranick, General Manager of Precision Oncology at Exact Sciences, vested 3,954 shares of common stock from restricted stock units.
- On February 27, 2024, Baranick sold 2,027 shares at $56.89 per share to cover withholding taxes related to the vesting of restricted stock units.
- Following these transactions, Baranick directly owns 11,694 shares of common stock and indirectly owns 454 shares through a 401(k) plan.
- Baranick also holds 51,042 vested and unvested options and restricted stock units.
- On February 26, 2024, Baranick was granted 19,793 restricted stock units that vest in four equal annual installments beginning on February 28, 2025.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.
Future Outlook
The document outlines future vesting dates for the granted restricted stock units, with the first vesting date being February 28, 2025.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, providing transparency to investors about insider activity. It is common for executives to receive stock options and restricted stock units as part of their compensation packages, and their transactions are closely monitored.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of shares held by an insider.
- The sale of shares to cover taxes could slightly increase the supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Vesting of 3,954 restricted stock units and grant of 19,793 restricted stock units |
| 02/27/2024 | Sale of 2,027 shares at $56.89 per share |
| 02/28/2025 | First vesting date for the 19,793 restricted stock units granted on February 26, 2024 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.